BoxOne Ventures is a privately held, Montreal-based early-stage investment firm that invests its own capital in entrepreneurs building transformative companies. Founded in 2010 by Josh Felker and Arvind Ramanathan, the firm focuses on biotechnology, the future of food, AI, clean energy, and longevity science, backing founders from napkin-stage through IPO.
Deal activity decreased year-over-year (1 deal in the last 12 months vs 3 prior). Their most common stage is seed (59% of deals). Average disclosed round size is $14.6M (across 24 rounds with reported amounts).
Portfolio
27
Fund Size
—
Top Stage
Seed
Last 12 Mo
1
Team
Josh Felker
Managing Partner
Josh Felker
Managing Partner
Felicity Meyer
Investment Manager
Milad Alucozai
Investor
Rebecca Allan
Investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| NNutrumami | Pre-Seed | — | Sep 2026 |
 Mycroft | Growth | $3.5M | Sep 2025 |
| SSUMM Ingredients | Seed | — | Sep 2025 |
 Stately Bio | Seed | $12M | May 2025 |
 Stately Bio | Seed | $12M | Jan 2025 |
 Talus Bioscience | Seed | $11.2M | Aug 2024 |
| OOpalia | Seed | — | Mar 2024 |
| AAxonis Therapeutics | Series A | $115M | Jan 2024 |
| Mycroft | Pre-Seed | $1.2M | Jan 2024 |
 Vivid Machines | Seed | $4.3M | Apr 2023 |
 Nimble Science | Seed | $2M | Apr 2023 |
 HumanFirst | Seed | — | Jan 2023 |
 Seqera | Series A | — | Oct 2022 |
 Spiderwort | Series A | $13.2M | Jul 2022 |
 Drugbank | Seed | — | Apr 2022 |
 Shakepay | Series A | $34.4M | Jan 2022 |
 Arpeggio | Series A | $20M | Jan 2022 |
 Injective | Seed | $40M | Jan 2022 |
 Colabra | Pre-Seed | $1.5M | Sep 2021 |
| Seqera | Seed | $5.5M | Sep 2021 |
 Botpress | Series A | $15M | Apr 2021 |
 Pathway Medical inc. | Seed | $5M | Jan 2021 |
| WWallit | Seed | $2.6M | Oct 2019 |
| Injective | Seed | $2.6M | Jan 2019 |
 Dispersa | Seed | — | — |
Top Co-Investors
Last updated: 20 October 2026